Evidence map›Paper›PMID 34044872›Full record

ArticleBiotechnology for biofuels2021

Novel molecular biological tools for the efficient expression of fungal lytic polysaccharide monooxygenases in Pichia pastoris.

Lukas Rieder, Katharina Ebner, Anton Glieder, Morten Sørlie

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Engineering small peptide secretion inFrontiers in bioengineering and biotechnology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Lukas Rieder *Faculty of Chemistry, Biotechnology, and Food Sciences, Norwegian University of Life Sciences (NMBU), Ås, Norway.
Katharina Ebner *Bisy GmbH, Hofstätten a. d. Raab, Austria.
Anton GliederInstitute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, Graz, Austria.
Morten SørlieFaculty of Chemistry, Biotechnology, and Food Sciences, Norwegian University of Life Sciences (NMBU), Ås, Norway. morten.sorlie@nmbu.no.ORCID http://orcid.org/0000-0001-7259-6710
Norwegian University of Life Sciences · NOInstitute of Molecular Biotechnology · AT

Funding

Horizon 2020 Framework Programme 722390
6 · The paper itself

Abstract

backgroundLytic polysaccharide monooxygenases (LPMOs) are attracting large attention due their ability to degrade recalcitrant polysaccharides in biomass conversion and to perform powerful redox chemistry.

resultsWe have established a universal Pichia pastoris platform for the expression of fungal LPMOs using state-of-the-art recombination cloning and modern molecular biological tools to achieve high yields from shake-flask cultivation and simple tag-less single-step purification. Yields are very favorable with up to 42 mg per liter medium for four different LPMOs spanning three different families. Moreover, we report for the first time of a yeast-originating signal peptide from the dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 1 (OST1) form S. cerevisiae efficiently secreting and successfully processes the N-terminus of LPMOs yielding in fully functional enzymes.

conclusionThe work demonstrates that the industrially most relevant expression host P. pastoris can be used to express fungal LPMOs from different families in high yields and inherent purity. The presented protocols are standardized and require little equipment with an additional advantage with short cultivation periods.

Indexed as

LPMOPichia pastorisSignal peptide cleavingSimplified expression

Identifiers

PMID34044872
PMCPMC8161572
OpenAlexW3165297086

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.